Burry's Scion Asset Adds Cigna, BP, Exits Oracle, CVS, Among Q1 Buys, Sells
Michael Burry's Scion Asset Management 13F Reports 360K Shares Of JD, 125K Shares Of BABA, 25K Shares Of HCA, 125K Shares Of C, 440,729K Shares Of PHYS, 90K Shares Of SQ, 20K Shares Of CI, 85K Shares Of AAP, 175K Shares Of BP, 125K Shares Of VTLE,...
Michael Burry's Scion Asset Management 13F Reports 360K Shares Of JD, 125K Shares Of BABA, 25K Shares Of HCA, 125K Shares Of C, 440,729K Shares Of PHYS, 90K Shares Of SQ, 20K Shares Of CI, 85K Shares
The Cigna Group Ranks No. 7 in Fair360 Top 50 Companies
Global health company The Cigna Group (NYSE: CI) announced today that it is No. 7 on Fair360's 2024 Top 50 Companies – seven spots higher than last...
Form 144 | The Cigna Group(CI.US) Officer Proposes to Sell 2.07 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $The Cigna Group(CI.US)$ Officer Agoglia Hoeltzel Mary T intends to sell 5,946 shares of its common stock on May 14, with a total market value of approximately $2.07 mi
Form 144 | The Cigna Group(CI.US) Officer Proposes to Sell 3.73 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $The Cigna Group(CI.US)$ Officer Eder Noelle K intends to sell 10,700 shares of its common stock on May 14, with a total market value of approximately $3.73 million.
Looking Into Cigna Group's Recent Short Interest
Cigna Group's (NYSE:CI) short percent of float has fallen 29.44% since its last report. The company recently reported that it has 3.95 million shares sold short, which is 1.39% of all regular shares t
Bernstein Adjusts Price Target on Cigna to $411 From $389
Cigna (CI) has an average rating of outperform and price targets ranging from $349 to $432, according to analysts polled by Capital IQ. Price: 350.82, Change: -0.15, Percent Change: -0.04
Oscar Health Inc (OSCR) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
Form 144 | The Cigna Group(CI.US) Officer Proposes to Sell 1.26 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $The Cigna Group(CI.US)$ Officer Neville Everett intends to sell 3,622 shares of its common stock on May 9, with a total market value of approximately $1.26 million. N
Jefferies Adjusts Price Target on Cigna to $407 From $385, Keeps Buy Rating
Cigna (CI) has an average outperform rating and a price target range of $349 to $432, according to analysts polled by Capital IQ.
Is Cigna Group (NYSE:CI) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
U.S. Expands Federal Health Coverage for DACA Immigrants
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Form 144 | The Cigna Group(CI.US) Officer Proposes to Sell 1.33 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 3, $The Cigna Group(CI.US)$ Officer Neville Everett intends to sell 3,904 shares of its common stock on May 3, with a total market value of approximately $1.33 million. N
Cigna Corporation (NYSE:CI) Q1 2024 Earnings Call Transcript
Canto Fitzgerald: Maintaining the Cigna Group (CI.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $384.00 to $400.00.
Canto Fitzgerald: Maintaining the Cigna Group (CI.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $384.00 to $400.00.
Cantor Fitzgerald Maintains Overweight on Cigna Group, Raises Price Target to $400
Cantor Fitzgerald analyst Sarah James maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $384 to $400.
4 HMO Stocks to Watch Amid Persistent Industry Challenges
Cigna Group Is Maintained at Outperform by Oppenheimer
Cigna Group Is Maintained at Outperform by Oppenheimer
Cigna Group Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 16.86% Oppenheimer $370 → $400 Maintains Outperform 04/10/2024 12.18% Cantor Fitzgerald → $384
No Data